Kindlin-2 inhibits Nlrp3 inflammasome activation in nucleus pulposus to maintain homeostasis of the intervertebral disc

被引:0
|
作者
Sheng Chen
Xiaohao Wu
Yumei Lai
Di Chen
Xiaochun Bai
Sheng Liu
Yongchao Wu
Mingjue Chen
Yuxiao Lai
Huiling Cao
Zengwu Shao
Guozhi Xiao
机构
[1] Huazhong University of Science and Technology,Department of Orthopaedics, Union Hospital, Tongji Medical College
[2] Shenzhen Key Laboratory of Cell Microenvironment,Department of Biochemistry, School of Medicine, Southern University of Science and Technology, Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research
[3] Rush University Medical Center,Department of Orthopedic Surgery
[4] Chinese Academy of Sciences,Research Center for Human Tissues and Organs Degeneration, Shenzhen Institutes of Advanced Technology
[5] Southern Medical University,Department of Cell Biology, School of Basic Medical Sciences
[6] Chinese Academy of Sciences,Centre for Translational Medicine Research and Development, Institute of Biomedical and Health Engineering, Shenzhen Institute of Advanced Technology
来源
Bone Research | / 10卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Intervertebral disc (IVD) degeneration (IVDD) is the main cause of low back pain with major social and economic burdens; however, its underlying molecular mechanisms remain poorly defined. Here we show that the focal adhesion protein Kindlin-2 is highly expressed in the nucleus pulposus (NP), but not in the anulus fibrosus and the cartilaginous endplates, in the IVD tissues. Expression of Kindlin-2 is drastically decreased in NP cells in aged mice and severe IVDD patients. Inducible deletion of Kindlin-2 in NP cells in adult mice causes spontaneous and striking IVDD-like phenotypes in lumbar IVDs and largely accelerates progression of coccygeal IVDD in the presence of abnormal mechanical stress. Kindlin-2 loss activates Nlrp3 inflammasome and stimulates expression of IL-1β in NP cells, which in turn downregulates Kindlin-2. This vicious cycle promotes extracellular matrix (ECM) catabolism and NP cell apoptosis. Furthermore, abnormal mechanical stress reduces expression of Kindlin-2, which exacerbates Nlrp3 inflammasome activation, cell apoptosis, and ECM catabolism in NP cells caused by Kindlin-2 deficiency. In vivo blocking Nlrp3 inflammasome activation prevents IVDD progression induced by Kindlin-2 loss and abnormal mechanical stress. Of translational significance, adeno-associated virus-mediated overexpression of Kindlin-2 inhibits ECM catabolism and cell apoptosis in primary human NP cells in vitro and alleviates coccygeal IVDD progression caused by mechanical stress in rat. Collectively, we establish critical roles of Kindlin-2 in inhibiting Nlrp3 inflammasome activation and maintaining integrity of the IVD homeostasis and define a novel target for the prevention and treatment of IVDD.
引用
收藏
相关论文
共 50 条
  • [31] 3,4-Methylenedioxy-β-nitrostyrene Inhibits NLRP3 Inflammasome Activation by Blocking Assembly of the Inflammasome
    He, Yuan
    Varadarajan, Saranyaraajan
    Munoz-Planillo, Raul
    Burberry, Aaron
    Nakamura, Yuumi
    Nunez, Gabriel
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (02) : 1142 - 1150
  • [32] Cortistatin protects against intervertebral disc degeneration through targeting mitochondrial ROS-dependent NLRP3 inflammasome activation
    Zhao, Yunpeng
    Qiu, Cheng
    Wang, Wenhan
    Peng, Jiangfan
    Cheng, Xiang
    Shangguan, Yangtao
    Xu, Mingyang
    Li, Jiayi
    Qu, Ruize
    Chen, Xiaomin
    Jia, Suyi
    Luo, Dan
    Liu, Long
    Li, Peng
    Guo, Fengjin
    Vasilev, Krasimir
    Liu, Liang
    Hayball, John
    Dong, Shuli
    Pan, Xin
    Li, Yuhua
    Guo, Linlin
    Cheng, Lei
    Li, Weiwei
    THERANOSTICS, 2020, 10 (15): : 7015 - 7033
  • [33] Isoliquiritigenin inhibits NLRP3 inflammasome activation with CAPS mutations by suppressing caspase-1 activation and mutated NLRP3 aggregation
    Usui-Kawanishi, Fumitake
    Kani, Koudai
    Karasawa, Tadayoshi
    Honda, Hiroe
    Takayama, Nobuyuki
    Takahashi, Masafumi
    Takatsu, Kiyoshi
    Nagai, Yoshinori
    GENES TO CELLS, 2024, 29 (05) : 423 - 431
  • [34] Metformin inhibits activation of NLRP3 inflammasome and inflammatory response in preeclamptic rats
    Jia, Ran
    Ma, Huijing
    Hao, Huiniu
    Wang, Fang
    Yang, Hailan
    GENE, 2024, 919
  • [35] The MUC1 mucin specifically inhibits activation of the NLRP3 inflammasome
    G Z Ng
    P Sutton
    Genes & Immunity, 2016, 17 : 203 - 206
  • [36] PX-12 inhibits NLRP3 inflammasome activation to treat psoriasis
    Hwang, T.
    Chen, K.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S191 - S191
  • [37] Bergapten inhibits NLRP3 inflammasome activation and pyroptosis via promoting mitophagy
    Luo, Tong
    Jia, Xin
    Feng, Wan-di
    Wang, Jin-yong
    Xie, Fang
    Kong, Ling-dong
    Wang, Xue-jiao
    Lian, Rui
    Liu, Xia
    Chu, Ying-jie
    Wang, Yao
    Xu, An-long
    ACTA PHARMACOLOGICA SINICA, 2023, 44 (9) : 1867 - 1878
  • [38] Obovatol inhibits NLRP3, AIM2, and non-canonical inflammasome activation
    Kim, Jeongeun
    Ahn, Huijeong
    Han, Byung-Cheol
    Shin, Hyunjung
    Kim, Jin-Chul
    Jung, Eui-Man
    Kim, Juyeol
    Yang, Heejung
    Lee, Jeonghyun
    Kang, Seung Goo
    Lee, Seung-Ho
    Lee, Geun-Shik
    PHYTOMEDICINE, 2019, 63
  • [39] Cortistatin Inhibits NLRP3 Inflammasome Activation of Cardiac Fibroblasts During Sepsis
    Zhang, Bo
    Liu, Yue
    Sui, Yu-Bin
    Cai, Huai-Qiu
    Liu, Wen-Xiu
    Zhu, Minling
    Yin, Xin-Hua
    JOURNAL OF CARDIAC FAILURE, 2015, 21 (05) : 426 - 433
  • [40] Nanaomycin E inhibits NLRP3 inflammasome activation by preventing mitochondrial dysfunction
    Matsui, Yudai
    Takemura, Naoki
    Shirasaki, Yoshitaka
    Takahama, Michihiro
    Noguchi, Yoshihiko
    Ikoma, Kenta
    Pan, Yixi
    Nishida, Shuhei
    Taura, Manabu
    Nakayama, Akiyoshi
    Funatsu, Takashi
    Misawa, Takuma
    Harada, Yoshie
    Sunazuka, Toshiaki
    Saitoh, Tatsuya
    INTERNATIONAL IMMUNOLOGY, 2022, 34 (10) : 505 - 518